PreveCeutical corrects warrant acceleration price to $0.08 from $0.10 in prior releases

• Preveceutical corrected prior disclosures on its non-brokered private placement warrant terms, revising the acceleration price to $0.08 per share from $0.10.
• The $0.08 acceleration price applies to all tranches of the offering, including the Aug. 4, 2026 fourth-tranche closing.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Preveceutical Medical Inc. published the original content used to generate this news brief via Newsfile (Ref. ID: 202608041720NEWSFILECNPR____20260804_308049_1) on August 04, 2026, and is solely responsible for the information contained therein.